| Primary |
| Product Used For Unknown Indication |
32.6% |
| Drug Use For Unknown Indication |
11.9% |
| Sinusitis |
7.6% |
| Urinary Tract Infection |
5.8% |
| Pneumonia |
4.5% |
| Bronchitis |
4.1% |
| Infection |
4.0% |
| Prophylaxis |
3.9% |
| Upper Respiratory Tract Infection |
3.7% |
| Hypertension |
3.6% |
| Lower Respiratory Tract Infection |
3.6% |
| Ear Infection |
2.9% |
| Cellulitis |
2.0% |
| Atrial Fibrillation |
1.6% |
| Asthma |
1.5% |
| Bronchopneumonia |
1.4% |
| Cholecystitis |
1.4% |
| Pharyngitis |
1.4% |
| Sinus Disorder |
1.4% |
| Anaesthesia |
1.2% |
|
| Vomiting |
11.9% |
| Urticaria |
11.2% |
| Anaphylactic Reaction |
8.3% |
| Pruritus |
8.3% |
| Rash |
6.5% |
| Pyrexia |
5.4% |
| Diarrhoea |
4.7% |
| Jaundice Cholestatic |
4.3% |
| Stevens-johnson Syndrome |
4.0% |
| Acute Hepatic Failure |
3.6% |
| Dyspnoea |
3.6% |
| Nausea |
3.6% |
| Death |
3.2% |
| Hypotension |
3.2% |
| Renal Failure Acute |
3.2% |
| Tachycardia |
3.2% |
| Toxic Epidermal Necrolysis |
3.2% |
| Clostridium Difficile Colitis |
2.9% |
| Weight Decreased |
2.9% |
| Hepatitis |
2.5% |
|
| Secondary |
| Product Used For Unknown Indication |
47.1% |
| Drug Use For Unknown Indication |
12.1% |
| Pneumonia |
5.2% |
| Otitis Media Acute |
4.4% |
| Hypertension |
2.9% |
| Infection |
2.6% |
| Pyrexia |
2.5% |
| Urinary Tract Infection |
2.5% |
| Bronchitis |
2.2% |
| Pneumonia Legionella |
2.2% |
| Pain |
2.0% |
| Sinusitis |
2.0% |
| Type 2 Diabetes Mellitus |
2.0% |
| Lung Disorder |
1.8% |
| Prophylaxis |
1.7% |
| Toothache |
1.6% |
| Rheumatoid Arthritis |
1.5% |
| Pneumonia Aspiration |
1.3% |
| Atrial Fibrillation |
1.2% |
| Genital Herpes |
1.2% |
|
| Stevens-johnson Syndrome |
10.5% |
| Rash |
8.3% |
| Erythema Multiforme |
6.1% |
| Hepatitis Acute |
6.1% |
| Neutropenia |
6.1% |
| Toxic Skin Eruption |
6.1% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
5.5% |
| Pruritus |
5.5% |
| Respiratory Distress |
5.5% |
| Vomiting |
5.5% |
| Hepatitis Cholestatic |
4.4% |
| Tubulointerstitial Nephritis |
4.4% |
| Clostridial Infection |
3.9% |
| Thrombocytopenia |
3.9% |
| Anaphylactic Reaction |
3.3% |
| Cholestasis |
3.3% |
| Drug Interaction |
3.3% |
| Death |
2.8% |
| Jaundice |
2.8% |
| Pancytopenia |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.4% |
| Drug Use For Unknown Indication |
10.6% |
| Hypertension |
6.1% |
| Prophylaxis |
5.9% |
| Pain |
4.8% |
| Diffuse Large B-cell Lymphoma |
4.3% |
| Pneumonia |
4.2% |
| Contraception |
3.4% |
| Asthma |
3.0% |
| Depression |
2.5% |
| Crohn's Disease |
2.3% |
| Multiple Myeloma |
2.2% |
| Rheumatoid Arthritis |
2.2% |
| Infection |
1.9% |
| Bronchitis |
1.9% |
| Urinary Tract Infection |
1.8% |
| Anxiety |
1.8% |
| Migraine |
1.6% |
| Abdominal Pain |
1.6% |
| Epilepsy |
1.6% |
|
| Renal Failure Acute |
9.2% |
| Urinary Tract Infection |
8.9% |
| Pneumonia |
7.8% |
| Pulmonary Embolism |
7.5% |
| Vomiting |
7.5% |
| Pain |
6.0% |
| Anxiety |
5.7% |
| Atrial Fibrillation |
5.2% |
| Hypotension |
4.6% |
| Weight Decreased |
4.6% |
| Renal Failure |
4.0% |
| Diarrhoea |
3.4% |
| Small Intestinal Obstruction |
3.4% |
| White Blood Cell Count Decreased |
3.4% |
| Death |
3.2% |
| Deep Vein Thrombosis |
3.2% |
| Drug Interaction |
3.2% |
| Pyrexia |
3.2% |
| Ventricular Tachycardia |
3.2% |
| Cholecystitis Chronic |
2.9% |
|
| Interacting |
| Atrial Fibrillation |
18.0% |
| Hypertension |
16.0% |
| Pneumonia |
12.0% |
| Drug Use For Unknown Indication |
10.0% |
| Diabetes Mellitus |
4.0% |
| Ear Infection |
4.0% |
| Gout |
4.0% |
| Lung Disorder |
4.0% |
| Nasopharyngitis |
4.0% |
| Systemic Lupus Erythematosus |
4.0% |
| Bladder Disorder |
2.0% |
| Bronchitis |
2.0% |
| Dental Discomfort |
2.0% |
| Hyperlipidaemia |
2.0% |
| Immunosuppression |
2.0% |
| Phlebitis |
2.0% |
| Productive Cough |
2.0% |
| Pulmonary Embolism |
2.0% |
| Renal Failure Chronic |
2.0% |
| Tobacco User |
2.0% |
|
| Drug Interaction |
16.7% |
| International Normalised Ratio Increased |
16.7% |
| Oliguria |
16.7% |
| Hepatitis Cholestatic |
8.3% |
| Prothrombin Time Shortened |
8.3% |
| Retching |
8.3% |
| Sputum Purulent |
8.3% |
| Systemic Lupus Erythematosus |
8.3% |
| Weight Increased |
8.3% |
|
